Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Minnesota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Minnesota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Minnesota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Abdhish Bhavsar (NPI 1396776951)

Field	Value
Entity Type	Individual
Organization	Abdhish Bhavsar
Address	710 E 24th St Ste 304
City	Minneapolis
State	MN
ZIP	55404
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	July 5, 2006

Payer Source	Total Paid
Medicare	$2.3M
Medicaid	$0

Key Findings

This provider is a retina specialist whose Medicare billing is dominated by intravitreal anti‑VEGF therapy: Q5128 (ranibizumab‑eqrn biosimilar) and J0178 (aflibercept) together generate $962.4K (41.0%) and $711.7K (30.3%) of revenue, respectively, and are central to clinical activity and revenue generation. High volumes of diagnostic imaging and intermediate ophthalmology visits further support an injection‑and‑monitoring practice model rather than a general ophthalmology mix.

Revenue is highly concentrated: the top three Medicare codes (Q5128, J0178, 67028) account for 77.6% of this provider's total Medicare revenue, with 67028 contributing $147.7K (6.3%). That concentration signals material reliance on a small set of procedure and drug services for the $2.3M in Medicare revenue on file.

This profile is effectively single‑payer at scale: total Medicare revenue is $2.3M and there is no Medicaid billing on file, so the provider’s public‑payer footprint is concentrated entirely in Medicare. The lack of Medicaid billing reduces payer diversification and means Medicaid trends cannot be used to assess in‑state competitive positioning for this NPI.

Competitive standing varies by code: Q5128 is a national high‑volume outlier, ranking #17 of 373 (96th percentile; notably above typical national volume for this code), indicating unusually large ranibizumab biosimilar throughput compared with peers. By contrast, J0178 ranks #1261 of 3204 (61th percentile; typical, unremarkable volume for this code), so aflibercept usage is more ordinary relative to the national peer set.

Diagnostic and monitoring services are extreme outliers in national volume: 92012 has 1.4K claims and $90.8K revenue (3.9%) and ranks #230 of 17177 (99th percentile; extreme outlier), while 92134 has 2.9K claims and $83K revenue (3.5%) and ranks #461 of 26868 (98th percentile; extreme outlier). These high imaging and exam volumes are consistent with a high‑throughput injection clinic that performs frequent follow‑up testing.

Surgical retina work appears limited relative to injection and imaging activity: vitrectomy code 67042 shows 19 claims and $17K revenue (0.7%) and ranks #574 of 1087 (44th percentile), indicating the provider performs comparatively fewer surgical retinal procedures. The coding mix therefore points to a practice focused on medical retina management rather than operative volume.

Use of other biologic and unclassified drug codes is present but secondary: J3590 (unclassified biologics) accounts for $122.4K (5.2%) and ranks #57 of 631 (91th percentile; typical, unremarkable volume for this code), while J9035 (bevacizumab) contributes $9.3K (0.4%). This suggests occasional use of alternative biologic agents or billing pathways alongside the dominant ranibizumab and aflibercept administrations.

The provider has long tenure on file, with NPI enumerated 2006-07-05 (~20 years ago), consistent with an established referral footprint and mature clinical operations. Combined with concentrated Medicare revenue and extreme imaging volumes, the data indicate a stable, injection‑focused retina practice serving primarily Medicare beneficiaries.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

23 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	4,440	$220	$962.4K
J0178	Injection, aflibercept, 1 mg	1,030	$690	$711.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,540	$100	$147.7K
J3590	Unclassified biologics	560	$220	$122.4K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	1,360	$70	$90.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,860	$30	$83K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	740	$80	$60K
J2778	Injection, ranibizumab, 0.1 mg	220	$180	$40.4K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	160	$160	$25.4K
Q5124	Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg	130	$180	$21.9K

Showing 1–10 of 23

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Minnesota Distribution

Abdhish Bhavsar — 7 of 23 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Minnesota

Full comparison — all codes billed, vs. state median

23 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	16	40	580	$690	$743.4K
Q5128	2	20	1,410	$220	$393.8K
J2778	15	20	500	$180	$121K
J3590	2	10	220	$230	$73.7K
67028	11	80	420	$90	$64.8K
Q5124	5	10	200	$170	$49.2K
67042	9	10	20	$1,300	$48K
J7312	1	10	130	$160	$20.7K
J9035	25	40	220	$50	$16.9K
92014	8	830	100	$80	$11.9K

Showing 1–10 of 23

Related Providers

Other providers that share a Tax Identification Number (TIN) with Abdhish Bhavsar, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Hennepin Healthcare System, Inc	MN	General Acute Care Hospital	$420.8K	$708.9M
Hennepin County	MN	Case Manager/Care Coordinator	$0	$34.9M
Vitreoretinal Surgery PLLC	MN	Ophthalmology Physician	$0	$27.8M
Hennepin Healthcare System, Inc	MN	Home Health Agency	$0	$23.2M
Hennepin Healthcare System, Inc	MN	Clinic/Center	$0	$12.3M
David Williams	MN	Retina Specialist (Ophthalmology) Physician	$5.5M	$0
David Parke	MN	Ophthalmology Physician	$4.8M	$0
Sundeep Dev	MN	Ophthalmology Physician	$4.5M	$0
John Davies	MN	Ophthalmology Physician	$3.9M	$0
Polly Quiram	MN	Ophthalmology Physician	$3.7M	$0

Nearby Providers

Other providers in the same ZIP code as Abdhish Bhavsar, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nu-way House Inc	MN	Substance Abuse Rehabilitation Facility	$0	$200.8M
Childrens Health Care	MN	Children's Hospital	$0	$100M
Midwest Home Health Care, Inc.	MN	Home Health Agency	$0	$73.5M
Midwest Quality Home Care, Inc.	MN	Home Health Agency	$0	$66.7M
Regents Of The University Of Minnesota	MN	Federally Qualified Health Center (FQHC)	$0	$55.2M
Minnesota Professional Health Services,inc	MN	Home Health Agency	$0	$51.9M
Park Ave Center Inc	MN	Substance Use Disorder Rehabilitation Clinic/Center	$0	$50.8M
Minnesota Quality Care, Inc.	MN	Home Health Agency	$0	$48.4M
Direct Home Health Care, Inc.	MN	Home Health Agency	$0	$30.7M
Aaa A-z Friendly Languages Inc	MN	Interpreter	$0	$29.4M

Abdhish Bhavsar — Billing Profile & Reimbursement Data

Sign up for Abdhish Bhavsar — Billing Profile & Reimbursement Data policy alerts

Abdhish Bhavsar — Billing Profile & Reimbursement Data

Sign up for Abdhish Bhavsar — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References